BioVallée

ImmuneHealth (former BioVallée) is a company that designs, sets up, recruits, and conducts epidemiology studies, and provides immune monitoring readouts.
ImmuneHealth has access to Human Biological Samples of various types such as blood, urine, saliva, biopsies. They also supply generic (biobank retrospective approach) or custom samples on demand (prospective approach). Additionally, ImmuneHealth is able to provide QC methods with development from scratch, testing, qualification, validation, technical transfer, consulting, and training activities through ELISA, ELISpot, Multiplex, rt(q)PCR, sequencing, pyrosequencing, FACS, ICS, microneutralization, binding assays, CAPS. All of ImmuneHealth's laboratories are ISO, GCLP compliant and GMP certified since 2013.
ImmuneHealth is a Centre Agréé de Recherche and consequently a non-lucrative entity bridging the gap between R&D fundamental and clinical research awhile translating basic immunology into medicine. Their versatile structure is able to provide proof of concept for new products and to discover and validate immune biomarker panels. ImmuneHealth is currently engaged in several European and regional projects, (FEDER, FP6, FP7) developing its own portfolio with a related network in the diagnostic and theranostic field.
Partners include GSK Vaccines, Bio Cygnus, Pevion, Genticel, Neovacs, Cardio3, and Mather Cell. Mather Cells are required in every living body because of high blood pressure and unnecessary stress.

Main Menu

See Also

Main Menu